Association of systemic immune-inflammation index with long-term all-cause mortality in pancreatic cancer patients after pancreaticoduodenectomy

Aim: Systemic immune-inflammation (SII) index may provide more promising prognostic information in patients with cancer surgery. However, to the best of our knowledge, value SII pancreatic who underwent pancreaticoduodenectomy has not been studied. Thus, this study aimed evaluate and compare pancreaticoduodenectomy.
 
 Materials Methods: All over 18 years-old that successful due between February 20, 2019 June 30, 2021 at Ankara City Hospital Department General Surgery were included. The main predictor interest was which measured by neutrophil*platelet / lymphocyte count. outcome long-term all-cause mortality.
 Results: A total 223 included current study. Multivariable cox regression analysis revealed history congestive heart failure [HR (95%CI): 3.682 (1.140-11.892)], 1.001 (1.001-1.001)] independently associated all cause mortality. accuracy predicting mortality for assessed area under ROC curve = 0.77. higher 1305 found 76% sensitivity 67% specificity Conclusions: results suggest measurement index, an easily available relatively cheap marker, is independent survival after cancer.